TrialAIDS (London, England)2019

In-vivo administration of histone deacetylase inhibitors does not impair natural killer cell function in HIV+ individuals.

Carolina Garrido et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.